viloxazine - Page 1 | CARLAT PUBLISHING

ADHD Undone: A Telehealth Tale

September 14, 2026

Chris Aiken, MD and Kellie Newsome, PMHNP

A Silicon Valley founder built a telehealth company to make ADHD treatment as easy as ordering takeout, until federal prosecutors traced 37 million pills of Adderall back to the clinic. We follow Done from venture-backed startup to criminal conviction, and ask what the case means for how we diagnose and treats ADHD. Plus: a new FDA approval adds a third option to the ADHD reuptake-inhibitor family.

Clinical Update

ADHD Update 2025: New Treatments and Current Approaches for Co-Occurring Conditions

July 1, 2025

Anne Buchanan, DO

Anne Buchanan, DO. Child and adolescent psychiatrist; Medical Director, Caring Transitions Program, NYC Health + Hospitals, New York, NY.

Dr. Buchanan has no financial relationships with companies related to this material.

Where is ADHD care today? This comprehensive update covers the latest stimulant formulations, nonstimulant innovations, and digital therapeutics. We also provide evidence-based approaches for managing ADHD with common comorbidities including anxiety, depression, autism, bipolar disorder, and psychosis.

Viloxazine for ADHD

November 5, 2021

Thomas Jordan, MD.

Thomas Jordan, MD. Dr. Jordan has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

This repurposed antidepressant was recently approved in ADHD, but how does it compare with other treatments?

Viloxazine (Qelbree): A Faster Strattera?

May 20, 2021

Joshua Feder, MD, and Talia Puzantian, PharmD, BCPP.

Joshua Feder, MD, and Talia Puzantian, PharmD, BCPP. Dr. Feder and Dr. Puzantian have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

As of April, 2021, we have a brand new non-stimulant medication approved for treatment of ADHD in the US. Are we excited? Does this represent an advance over other efforts to produce effective non-stimulant medications for ADHD, or is it another instance of ‘me too’? What does the supporting research tell us? And what side effects do we need to watch out for? Read and learn.